From February 26 to 27, 2025, Toda Pharma participated in Women’s Health Professional Care in London, a major event dedicated to innovation and the needs of healthcare professionals in the field of women’s health.
An event focused on innovation in women's health
The Women’s Health Professional Care conference brought together more than 500 healthcare professionals, including general practitioners, midwives, specialized nurses, and pharmacists. This must-attend event featured a comprehensive scientific program addressing key topics such as menstrual health, fertility, menopause, mental health, and gynecological care.
Through lectures, hands-on workshops, and discussion forums, participants were able to update their knowledge and discover the latest innovations in medical devices and diagnostic solutions tailored to women’s specific needs.
Toda Pharma: A company committed to making women's healthcare accessible
Our expert Naama, who was at the trade show, had the opportunity to speak with many healthcare professionals about the rapid diagnostic tests developed by Toda Pharma. Our solutions address the real-world challenges faced by healthcare practices, with a focus on ease of use, reliability, and accessibility.
This presence reaffirms our strong commitment to more inclusive women’s health by facilitating screening and diagnosis through high-performance tools tailored for frontline professionals.
Innovative solutions for healthcare professionals in obstetrics
At the event, Toda Pharma presented two flagship tests designed for obstetrics:
- Toda AmnioDiag 5: a rapid and reliable test for detecting premature rupture of the fetal membranes (PROM) right at the patient’s bedside, enabling prompt and appropriate care.
- Toda fFN Diag : an innovative test for detecting fetal fibronectin, a key biomarker for assessing the risk of preterm birth, helping healthcare providers anticipate and adjust their interventions.
These solutions demonstrate our commitment to providing professionals with practical tools to improve maternal health.
A place for discussion and continuing education
The conference also provided an opportunity for fruitful discussions among participants, fostering the exchange of best practices and continuing education. These interactions contribute to the advancement of healthcare and the dissemination of the latest developments in women’s health.
For Toda Pharma, it was a valuable opportunity to strengthen its professional network in London and explore new opportunities for collaboration with organizations dedicated to women’s health.
Conclusion: Toda Pharma, a key partner in women's health
Participation in Women’s Health Professional Care 2025 demonstrates Toda Pharma’s ongoing commitment to innovation and supporting healthcare professionals in women’s care. By offering effective and accessible rapid diagnostic solutions, we contribute to better women’s health for the benefit of patients and practitioners.
We thank all the professionals we met and remain committed to continuing to develop tools tailored to today’s challenges.